Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dodecyl Creatine Ester - CERES BRAIN Therapeutics

Next Previous
X
Search
Drug Profile

Dodecyl Creatine Ester - CERES BRAIN Therapeutics

Alternative Names: CBT-101 - CERES BRAIN Therapeutics; Dodecyl creatine ester hydrochloride - CERES BRAIN Therapeutics

Latest Information Update: 25 Apr 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CERES BRAIN Therapeutics
  • Class Acetates; Urea compounds
  • Mechanism of Action Creatine replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - X-linked creatine deficiency
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Mitochondrial disorders; X-linked creatine deficiency

Most Recent Events

  • 24 Apr 2024 Preclinical trials in Mitochondrial disorders in France prior to April 2024 (Intranasal) (Ceres Brain therapeutics pipeline, April 2024)
  • 22 Apr 2022 Preclinical trials in X-linked creatine deficiency in France (Intranasal) (CERES BRAIN Therapeutics website, April 2022)
  • 03 Sep 2021 CBT 101 - CERES BRAIN Therapeutics receives Orphan Drug status for X-linked creatine deficiency in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top